Nuntius Therapeutics

Cell and Gene
Share

We are overcoming the biggest challenge for DNA, RNA and CRISPR therapies: Delivering large genetic payloads into the correct cells.

Our pipeline includes therapies for currently incurable rare diseases. Selected industry partners can also license our cell-specific delivery technology.

Stevenage Bioscience Catalyst is the UK's leading open innovation campus with a focus on therapeutics.

Learn more

We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.